PHARMACOEPIDEMIOLOGIC ANALYSIS OF ST-ELEVATION MYOCARDIAL INFARCTION REPERFUSION THERAPY AT SARATOV REGION HOSPITALS OF DIFFERENT TYPES
https://doi.org/10.20996/1819-6446-2009-5-6-7-12
Abstract
Aim. To evaluate the real practice of thrombolytic therapy of patients with ST-elevation myocardial infarction (STEMI) at cardiological departments of Saratov and Saratov region hospitals.
Material and methods. Retrospective pharmacoepidemiologic study was carried out. Case histories of STEMI patients discharged from cardiologic departments of several central district hospitals (CDH) of Saratov region, cardiologic department of one of Saratov general municipal hospitals (MH) and urgent cardiology department of Saratov clinical hospital (CH) in 2006 were analyzed.
Results. In CH all patients received thrombolytic therapy given they did not have contraindications and were admitted to the hospital timely. Few patients received thrombolytic therapy in MH and CDH in 2006.
Conclusion. Correlation between hospital type and quality of STEMI management has been revealed.
About the Authors
O. V. Reshetko
Saratov Research Institute for Cardiology of Federal Agency for Provision of High Technology Medical Aid,
Saratov State Medical University named after V.I. Razumovsky
Russian Federation
Russian Federation
Chernyshevskogo ul. 141, Saratov, 410028
Bolshaya Kazachia ul. 112, Saratov, 410012
N. V. Furman
Saratov Research Institute for Cardiology of Federal Agency for Provision of High Technology Medical Aid,
Saratov State Medical University named after V.I. Razumovsky
Russian Federation
Russian Federation
Chernyshevskogo ul. 141, Saratov, 410028
Bolshaya Kazachia ul. 112, Saratov, 410012
R. M. Magdeev
Saratov Research Institute for Cardiology of Federal Agency for Provision of High Technology Medical Aid,
Saratov State Medical University named after V.I. Razumovsky
Russian Federation
Russian Federation
Chernyshevskogo ul. 141, Saratov, 410028
Bolshaya Kazachia ul. 112, Saratov, 410012
Ya. P. Ya.P. Dovgalevskiy
Saratov Research Institute for Cardiology of Federal Agency for Provision of High Technology Medical Aid,
Saratov State Medical University named after V.I. Razumovsky
Russian Federation
Russian Federation
Chernyshevskogo ul. 141, Saratov, 410028
Bolshaya Kazachia ul. 112, Saratov, 410012
References
1. Diagnostics and treatment of acute ST-elevation myocardial infarction. Oganov R.G., Mamedov M.N., editors. National clinical guidelines. M. Medi EKSPO;2009.p.165-227 (in Russian). / Диагностика и лечение больных острым инфарктом миокарда с подъемом сегмента ST электрокардиограм- мы. В кн. Оганов Р.Г., Мамедов М.Н., редакторы. Национальные клинические рекомендации. М.: Меди ЭКСПО; 2009. С.165-227.
2. Antman E.M., Anbe D.T., Armstrong P.W. et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients With Acute Myocardial Infarction). J Am Coll Cardiol 2004;44(3):671–719.
3. Bassand J.P., Danchin N., Filippatos G. et al. Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology. Eur Heart J 2005;26(24): 2733-41.
4. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2003;24(1):24-66.
5. Eagle K.A., Nallamothu B.K., Metha R.H. et al. Trends in acute reperfusion for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J 2008;29(5):609-17.
6. Hordijk-Trion M., Lenzen M., Wijns W. et al. Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey. Eur Heart J 2006;27(6): 671–8.
7. Terkelsen C.J., Lassen J.F., Nørgaard B.L. et al. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort Eur Heart J 2005;26(1):18-26.
8. Cannon C.P. Primary percutaneous coronary interventions for all? JAMA 2002;287(15):1987–8.
9. Buiatti E., Barchielli A., Marchionni N. et al. Determinants of treatment strategies and survival in acute myocardial infarction: a population-based study in the Florence district, Italy Results of the acute myocardial infarction Florence registry (AMI-Florence). Eur Heart J 2003;24(13):1195-203.
10. AlterD.A., KoD.T., Newman A., Tu J.V. Factors explaining the under-use ofreperfusion therapy among ideal patients with ST-segment elevation myocardial infarction. Eur Heart J 2006;27(13):1539–49.
11. Iavelov I.S., Gratsianskii N.A. Register of Acute Coronary Syndromes in Russia: Management and Inhospital Outcomes in ST Elevation Acute Coronary Syndrome. Kardiologiia 2004;44(4):4-13 (in Russian). / Явелов И.С., ГрацианскийН.А. Российский регистр острых коронарных синдромов: лече- ние и исходы в стационаре при остром коронарном синдроме с подъемами сегмента ST. Кар- диология 2004;44(4):4-13.
12. Belenkov Iu.N., Mareev V.Iu. How we treat patients with cardiovascular diseases in real clinical practice. Ter Arkh. 2003;75(8):5-11 (in Russian). / Беленков Ю.Н., Мареев В.Ю. Как мы лечим больных с сердечно-сосудистыми заболеваниями в реальной клинической практике. Терапевтический архив 2003;75(8):5-11.
13. Fox K.A., Goodman S.G., Klein W. et al. Management of acute coronary syndromes. Variations in practice and outcome: Findings from the Global Registry of the Acute Coronary Events (GRACE). Eur Heart J 2002;23(15):1177-89.
14. Nallamothu B.K., Wang Y., Cram P. et al Acute Myocardial Infarction and CongestiveHeart Failure Outcomes at Specialty Cardiac Hospitals. Circulation 2007;116(20);2280-7.
15. Reed S.D., McMurray J.J., Velazquez E.J. et al. Geographic Variation in the Treatment of Acute Myocardial Infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) Trial. Am Heart J 2006;152(3):500-8.
16. Fox K.A., Goodman S.G., Anderson F.A.Jr. et al. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003;24(15):1414-24.
17. Hasdai D., Behar S., Wallentin L. et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in European and Mediterranean basin: The Euro Heart Survey Acute Coronary Syndomes (Euro Heart Survey ACS). Eur Heart J 2002;23(15):1190- 201.
18. Mandelzweig L., Battler A., Boyko V. et al. The second EuroHeart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J 2006;27(19):2285–93.
19. Kramer J.M., Newby L.K., Chang W.C. et al. International variation in the use of evidence-based medicines for acute coronary syndrome. Eur Heart J 2003;24(23):2133-41.
20. Di Chiara A., Chiarella F., Savonitto S. et al. Epidemiology of acute myocardial infarction in the Italian CCU network. The BLITZ Study. Eur Heart J 2003;24(18):1616–29.
21. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications forfibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343(8893):311–22.
22. Boersma E., Maas A.C., Deckers J.W., Simoons M.L. Early thrombolytic therapy in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348(9030):771–5.
23. Gersh B.J., Stone G.W., White H.D., Holmes D.R. Jr. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? JAMA 2005;293(8):979–86.
24. Karpov R.S., Markov V.A., Danilenko A.M. et al. Effectiveness of pre-hospital thrombolytic therapy in acute myocardial infarction. Kardiologiia 1992;32(9-10):23-6 (in Russian). / Карпов Р.С., Мар- ков В.А., Даниленко А.М. и др. Эффективность тромболитической терапии острого инфаркта миокарда на догоспитальном этапе. Кардиология 1992;32(9-10):23-6.
25. Thiele H., Kappl M.J., Linke A. et al. Influence of time-to-treatment, TIMI-flow grades, and ST-segment resolution on infarct size and infarct transmurality as assessed by delayed enhancement magnetic resonance imaging. Eur Heart J 2007;28(12):1433-9.
Review
For citations:
Reshetko O.V., Furman N.V., Magdeev R.M., Ya.P. Dovgalevskiy Ya.P. PHARMACOEPIDEMIOLOGIC ANALYSIS OF ST-ELEVATION MYOCARDIAL INFARCTION REPERFUSION THERAPY AT SARATOV REGION HOSPITALS OF DIFFERENT TYPES. Rational Pharmacotherapy in Cardiology. 2009;5(6):7-12. https://doi.org/10.20996/1819-6446-2009-5-6-7-12
Views:
664
Email this article 